As announced on
EARNINGS TREND
SEKm | 2023:3 | 2023:2 | 2023:1 | 2022:4 | 2212 | 2112 |
Net sales | 37,092 | 37,078 | 36,352 | 36,629 | 131,320 | 101,466 |
Gross profit | 10,683 | 10,454 | 10,359 | 9,935 | 32,026 | 29,144 |
Adjusted gross profit1 | 11,670 | 10,809 | 10,321 | 10,237 | 33,925 | 29,290 |
Adjusted operating profit before amortization of acquisition- related intangible assets (EBITA)1 | 5,147 | 4,617 | 4,281 | 4,112 | 12,047 | 11,451 |
Operating profit before amortization of acquisition-related intangible assets (EBITA) | 3,497 | 4,131 | 4,368 | 3,818 | 9,876 | 11,822 |
Amortization of acquisition-related intangible assets | -277 | -279 | -283 | -288 | -1,111 | -844 |
Adjusted operating profit1 | 4,870 | 4,338 | 3,998 | 3,824 | 10,936 | 10,607 |
Items affecting comparability | -1,967 | -519 | 87 | -305 | -2,445 | 371 |
Operating profit | 2,903 | 3,819 | 4,085 | 3,519 | 8,491 | 10,978 |
Financial items | -644 | -588 | -625 | -561 | -1,320 | -567 |
Profit before tax | 2,259 | 3,231 | 3,460 | 2,958 | 7,171 | 10,411 |
Adjusted profit before tax1 | 4,226 | 3,750 | 3,373 | 3,263 | 9,616 | 10,040 |
Income taxes | -696 | -786 | -809 | -736 | -2,006 | -2,398 |
Profit for the period from continuing operations | 1,563 | 2,445 | 2,651 | 2,222 | 5,165 | 8,013 |
Profit for the period from discontinued operations | 88 | 106 | 52 | 24 | 899 | 1,797 |
Profit for the period, total operations | 1,651 | 2,551 | 2,703 | 2,246 | 6,064 | 9,810 |
Earnings per share before and after dilution, continuing operation, SEK | 2.20 | 3.46 | 3.75 | 3.14 | 7.28 | 10.96 |
Adjusted earnings per share before and after dilution, continuing operation, | 4.83 | 4.26 | 3.93 | 3.75 | 11.60 | 11.18 |
Earnings per share before and after dilution, total operations, SEK | 2.26 | 3.53 | 3.79 | 3.15 | 7.93 | 12.27 |
1Excluding items affecting comparability. |
|
|
|
|
|
|
2Excluding items affecting comparability and amortization of acquisition-related intangible assets. |
|
|
NET SALES BY BUSINESS AREA
SEKm | 2023:3 | 2023:2 | 2023:1 | 2022:4 | 2212 | 2112 |
Health & Medical | 7,158 | 6,905 | 6,665 | 6,589 | 24,708 | 21,255 |
Consumer Goods | 19,729 | 20,056 | 20,257 | 20,454 | 72,241 | 55,821 |
Professional Hygiene | 10,184 | 10,123 | 9,422 | 9,617 | 34,393 | 24,392 |
Other | 21 | -6 | 8 | -31 | -22 | -2 |
Total | 37,092 | 37,078 | 36,352 | 36,629 | 131,320 | 101,466 |
ORGANIC SALES GROWTH BY BUSINESS AREA
(%) | 2023:3 | 2023:2 | 2023:1 | 2022:4 | 2212 | 2112 |
Health & Medical | 5.8 | 8.0 | 10.6 | 4.5 | 7.2 | 5.5 |
Consumer Goods | -0.4 | 5.7 | 14.8 | 18.4 | 17.6 | 0.2 |
Professional Hygiene | 5.7 | 11.7 | 22.6 | 20.7 | 25.4 | 5.8 |
Total | 2.4 | 7.7 | 15.9 | 16.0 | 17.3 | 2.6 |
SALES GROWTH, INCLUDING ORGANIC SALES GROWTH AND
ACQUISITIONS BY BUSINESS AREA
(%) | 2023:3 | 2023:2 | 2023:1 | 2022:4 | 2212 | 2112 |
Health & Medical | 5.8 | 8.0 | 10.6 | 6.4 | 9.6 | 6.6 |
Consumer Goods | 1.1 | 8.7 | 17.2 | 21.1 | 20.0 | 1.6 |
Professional Hygiene | 5.7 | 11.7 | 22.9 | 21.3 | 27.7 | 7.7 |
Total | 3.3 | 9.3 | 17.4 | 18.0 | 19.7 | 4.0 |
|
|
|
|
|
|
|
ADJUSTED EBITA BY BUSINESS AREA
SEKm | 2023:3 | 2023:2 | 2023:1 | 2022:4 | 2212 | 2112 |
Health & Medical | 1,188 | 947 | 777 | 719 | 2,904 | 3,800 |
Consumer Goods | 2,395 | 2,417 | 2,400 | 2,293 | 6,354 | 5,767 |
Professional Hygiene | 1,887 | 1,582 | 1,288 | 1,405 | 3,843 | 2,673 |
Other | -323 | -329 | -184 | -305 | -1,054 | -789 |
Total | 5,147 | 4,617 | 4,281 | 4,112 | 12,047 | 11,451 |
ADJUSTED OPERATING PROFIT BY BUSINESS AREA
SEKm | 2023:3 | 2023:2 | 2023:1 | 2022:4 | 2212 | 2112 |
Health & Medical | 979 | 737 | 560 | 499 | 2,058 | 3,082 |
Consumer Goods | 2,332 | 2,356 | 2,338 | 2,231 | 6,109 | 5,650 |
Professional Hygiene | 1,881 | 1,577 | 1,282 | 1,400 | 3,823 | 2,663 |
Other | -322 | -332 | -182 | -306 | -1,054 | -788 |
Total adjusted operating profit1 | 4,870 | 4,338 | 3,998 | 3,824 | 10,936 | 10,607 |
Financial items | -644 | -588 | -625 | -561 | -1,320 | -567 |
Profit before tax1 | 4,226 | 3,750 | 3,373 | 3,263 | 9,616 | 10,040 |
Income taxes | -995 | -941 | -803 | -815 | -2,206 | -2,474 |
Net profit for the period2 | 3,231 | 2,809 | 2,570 | 2,448 | 7,410 | 7,566 |
|
|
|
|
|
|
|
1Excluding items affecting comparability before tax amounting to: | -1,967 | -519 | 87 | -305 | -2,445 | 371 |
2Excluding items affecting comparability after tax amounting to: | -1,668 | -364 | 81 | -226 | -2,245 | 447 |
ADJUSTED EBITA MARGIN BY BUSINESS AREA
(%) | 2023:3 | 2023:2 | 2023:1 | 2022:4 | 2212 | 2112 |
Health & Medical | 16.6 | 13.7 | 11.7 | 10.9 | 11.8 | 17.9 |
Consumer Goods | 12.1 | 12.1 | 11.8 | 11.2 | 8.8 | 10.3 |
Professional Hygiene | 18.5 | 15.6 | 13.7 | 14.6 | 11.2 | 11.0 |
Total | 13.9 | 12.5 | 11.8 | 11.2 | 9.2 | 11.3 |
ADJUSTED GROSS MARGIN BY BUSINESS AREA
(%) | 2023:3 | 2023:2 | 2023:1 | 2022:4 | 2212 | 2112 |
Health & Medical | 42.0 | 39.0 | 37.8 | 36.3 | 37.4 | 42.7 |
Consumer Goods | 28.3 | 26.3 | 26.3 | 25.7 | 23.0 | 25.7 |
Professional Hygiene | 30.2 | 28.1 | 26.3 | 26.8 | 23.4 | 24.0 |
Total | 31.5 | 29.2 | 28.4 | 27.9 | 25.8 | 28.9 |
ADJUSTED RETURN ON CAPITAL EMPLOYED BY BUSINESS AREA
(%) | 2023:3 | 2023:2 | 2023:1 | 2022:4 | 2212 | 2112 |
Health & Medical | 13.3 | 10.7 | 9.1 | 8.3 | 8.7 | 12.8 |
Consumer Goods | 17.2 | 17.6 | 18.2 | 16.7 | 12.8 | 14.2 |
Professional Hygiene | 28.0 | 22.7 | 18.6 | 19.3 | 14.0 | 11.7 |
Total | 17.2 | 15.8 | 15.2 | 13.9 | 10.9 | 12.4 |
OPERATING CASH FLOW BY BUSINESS AREA
SEKm | 2023:3 | 2023:2 | 2023:1 | 2022:4 | 2212 | 2112 |
Health & Medical | 1,676 | 323 | 270 | 818 | 2,396 | 3,834 |
Consumer Goods | 2,235 | 1,732 | 1,760 | 1,043 | 3,567 | 5,152 |
Professional Hygiene | 2,370 | 1,782 | 951 | 1,344 | 3,219 | 2,311 |
Other | -227 | -990 | -111 | -585 | -1,503 | -1,552 |
Total | 6,054 | 2,847 | 2,870 | 2,620 | 7,679 | 9,745 |
NET SALES BY CATEGORY
(%) | 2212 |
Health & Medical | 19 |
of which |
|
Incontinence Products Health Care | 11 |
Medical Solutions | 8 |
Consumer Goods | 55 |
of which |
|
Incontinence Products Retail | 7 |
Feminine Care | 8 |
| 5 |
Consumer Tissue | 35 |
Professional Hygiene | 26 |
NET SALES PER REGION
(%) | 2212 |
62 | |
16 | |
16 | |
2 | |
Other | 4 |
For further information, please contact:
Per Lorentz, Vice President Corporate Communications, +46 73 313 30 55, per.lorentz@essity.com
Sandra Åberg, Vice President Investor Relations, +46 70 564 96 89, sandra.aberg@essity.com
https://news.cision.com/essity/r/essity-reports-vinda-as-discontinued-operations-as-of-q4-2023-and-publishes-updated-comparable-figur,c3896297
https://mb.cision.com/Main/15798/3896297/2504980.pdf
(c) 2023 Cision. All rights reserved., source